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Presentation of a clinical case
A 50-year old man was referred to our outpatient clinics by the
Conegliano Hospital Urological Department, where he had un-
dergone right percutaneous pielolithotomy for an obstructing
stone. Previously, he had had one calcium-oxalate stone which
passed spontaneously. His personal and familial history was
not significant. The patient was normotensive, and had normal
thyroid and renal functions. He was not taking any drug or nu-
tritional supplement.
The diagnostic workout of the stone metabolic risk disclosed a
very severe hypercalciuria (377 to 972 mg/day), occasionally
associated with borderline hypercalcemia. Serum phosphate
was in the normal range; other tests (citraturia, uricosuria, urine
and blood pH, blood bicarbonate) were also normal. A low cal-
cium diet and thiazide administration modified calciuria only
moderately, but thiazides induced modest, non-transient hyper-
calcemia (11.4 mg/dL). Calciuria was high even after fasting.
Secondary forms of neoplastic, granulomatous, and monoclon-
al disorders were ruled out, and primary hyperparathyroidism
was suspected. The thiazides-induced hypercalcemia was sug-
gestive of this condition. However, PTH levels were repeatedly
normal (37 ng/L, and 47 ng/L concomitant with the thiazide-in-
duced hypercalcemia), ionized calcium was in the normal
range, and the parathyroid US and nuclear scans were both
negative. 
Although bone densitometry showed normal values, bone
turnover was increased as evidenced by higher urine excretion
of cross-links and hydroxy-proline. This finding, together with
fasting hypercalciuria, suggested a renal form of hypercalciuria.
The patient was then treated with the lowest dosage of hy-
drochlorothiazide (12.5 mg), which did not induce hypercal-
cemia; potassium citrate 6 g/day was also administered with a
recommendation to increase water intake. 
In the following year, no new stone formed. However, calciuria
was again very high (>500 mg/day) and, for the first time, PTH
too was abnormally elevated (127, 138 ng/L). Parathyroid US
and nuclear scans were both negative. The hypothesis was ad-
vanced that hypercalciuria was primarily of renal (or bone) ori-
gin with secondary activation of the parathyroids. After a 2
week wash-out from thiazides, urine sodium excretion was still
high (241 mmol/day); therefore, a short trial with a hyposodic
diet was performed after which calciuria was significantly re-
duced, although it remained slightly elevated (310 mg/day).
The patient was thereafter strongly recommended to follow a
strict low sodium regimen together with hydrochlorothiazide (50
mg/day). A year later, PTH was decreased to normal values
(59, 64 ng/L), and serum calcium (10.0 mg/dL) and calciuria
(290 mg/day) were both in the normal range. No other stone
had formed in the meantime.
This case is interesting in three aspects: 1) the way it fits in dif-
ferent classifications of hypercalciuria; 2) it shows a need to
approach treatment by acting on different mechanisms; and 3)
it suggests the possibility of reversing secondary hyperparathy-
roidism.
A number of classification types of hypercalciuria have been
developed over time. Pak et al (1) classified hypercalciuria as
absorptive, renal or resorptive. In view of this classification, the
patient appeared to be affected by renal hypercalciuria during
his initial evaluation. According to Bataille et al (2) who, essen-
tially developing Pak’s original classification (1), proposed six
different patho-physiological types of hypercalciuria (absorptive
tp. I, tp. II, tp. III, renal, fasting and dietary-calcium-dependent),
our patient had a mixed form of renal and fasting hypercalci-
uria. Certainly, this case is atypical because it presents a num-
ber of conditions which are not distinctive of a single form of
hypercalciuria. Fasting hypercalciuria with normal serum calci-
um and PTH seem to indicate severe absorptive hypercalciuria
(3), but lack of response to low calcium diet, abnormal bone
turnover, and, occasionally, borderline abnormal values of
s rum calcium suggest a different etiology. However, the more
synthetic and clinically oriented classification recently proposed
by Pak himself (4), i.e., hypercalciuria with hypercalcemia, or
with high urinary sodium excretion, or absorptive and renal,
sounds more useful. Actually, it would classify our patient again
as having a mixed form of hypercalciuria, but characterized by
high urinary sodium excretion and renal leak of calcium. 
The Bataille and the first Pak classifications (1,2) did not ade-
quately recognize the role of the high sodium intake in the
pathogenesis of some forms of hypercalciuria, which is on the
contrary clearly acknowledged by the recent Pak classification
(4). Lack of recognition could depend on the well-known notion
at patients with renal hypercalciuria show an exaggerated
sodium urinary excretion when thiazides are given to block
sodium reabsorption in the distal tubule (5). However, in our
patient, the abnormal sodium urinary excretion was observed
w en he was not taking thiazides, suggesting that it was inde-
pendent from the renal leak of calcium and overlaps it.
Our patient, therefore, shows the possibility that there is over-
l p between a primary tubular defect responsible for the renal
le k of calcium (or a primary altered bone turnover), and a nu-
tritional condition, the high sodium dietary intake, and this as-
sociation induces, in turn, worsening of hypercalciuria. It was
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only after addressing both conditions that treatment succeeded
in reducing calciuria to the normal range, and in reverting sec-
ondary hyperparathyroidism. On the other hand, it is long
known that the hypocalciuric activity of thiazides is maximized
by the contemporaneous restriction of salt intake.
A diagnosis of primary hyperparathyroidism was advanced at
baseline assessment of the patient because of the borderline
high values of serum calcium and the hypercalcemic response
to thiazide administration. However, PTH levels were normal
as well as the US and nuclear scans. Furthermore, in primary
hyperparathyroidism calcium phosphate is the major con-
stituent of stones, while calcium oxalate, as in the present pa-
tient, predominates in renal hypercalciuria. We think that our
patient, due to the very high hypercalciuria, presented an over-
stimulation of the PTH axis; at his first assessment this was not
yet sufficient to give clearly abnormal PTH levels, but was al-
ready partially insensitive to calcium levels, as shown by the
relatively increased PTH level during the thiazide-induced hy-
percalcemia. In the first year of follow-up, persistence of severe
hypercalciuria worsened the condition leading to some escape
from normal regulation of parathyroids, and thus to the clearly
increased PTH levels. However, this process was still quite at
the initial stage as shown by its reversibility after one more
y ar of follow-up during which calciuria was successfully con-
trolled, and by lack of demonstration of parathyroid abnormali-
ties at the nuclear and US scans.
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